Maravai LifeSciences Holdings, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 29 →Insiders2 insiders bought $1.9M in 5 open-market buys. 1 insider sold $254,000, all 2 sales on a 10b5-1 plan.→HoldersGTCR $125.7MBlackRock $62.2MBraidwell $54.3M→PeersClosest companies: TXG, TKNO, PACB→
From the filings
Figures
- Revenue
- $208.8Mlast 12 months
- Net income
- −$77.4Mlast 12 months
- Operating cash flow
- −$39.5Mlast 12 months
- Cash and equivalents
- $70.1Mat the last balance sheet
- Total debt
- $147.1Mat the last balance sheet